- Home
- OM vs EDAP Comparison
OM vs EDAP Comparison
Compare OM & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- EDAP
- Stock Information
- Founded
- OM 2003
- EDAP 1979
- Country
- OM United States
- EDAP France
- Employees
- OM N/A
- EDAP N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OM Health Care
- EDAP Health Care
- Exchange
- OM Nasdaq
- EDAP Nasdaq
- Market Cap
- OM 50.5M
- EDAP 53.8M
- IPO Year
- OM 2020
- EDAP 1997
- Fundamental
- Price
- OM $16.58
- EDAP $2.21
- Analyst Decision
- OM Buy
- EDAP Buy
- Analyst Count
- OM 2
- EDAP 3
- Target Price
- OM $29.50
- EDAP $8.50
- AVG Volume (30 Days)
- OM 136.5K
- EDAP 77.7K
- Earning Date
- OM 05-07-2025
- EDAP 05-15-2025
- Dividend Yield
- OM N/A
- EDAP N/A
- EPS Growth
- OM N/A
- EDAP N/A
- EPS
- OM N/A
- EDAP N/A
- Revenue
- OM $115,273,000.00
- EDAP $66,378,507.00
- Revenue This Year
- OM $8.98
- EDAP $0.74
- Revenue Next Year
- OM $12.74
- EDAP $0.37
- P/E Ratio
- OM N/A
- EDAP N/A
- Revenue Growth
- OM N/A
- EDAP 6.11
- 52 Week Low
- OM $5.85
- EDAP $1.26
- 52 Week High
- OM $78.30
- EDAP $7.36
- Technical
- Relative Strength Index (RSI)
- OM 72.07
- EDAP 59.80
- Support Level
- OM $11.19
- EDAP $2.02
- Resistance Level
- OM $16.40
- EDAP $2.25
- Average True Range (ATR)
- OM 1.17
- EDAP 0.18
- MACD
- OM 0.49
- EDAP 0.06
- Stochastic Oscillator
- OM 96.24
- EDAP 83.84
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.